-

SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Nauticus Robotics, Inc. and Encourages Long-Term KITT / CLAQ Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Nauticus Robotics, Inc. (NASDAQ: KITT) (“Nauticus Robotics”) on behalf of the company’s long-term investors.

Nauticus Robotics develops and provides ocean robots, software, and services to the ocean industry. The current company was formed in September 2022 via a business combination with SPAC entity CleanTech Acquisition Corp. (NASDAQ: CLAQ), with Nauticus Robotics as the surviving, publicly traded entity.

Since the time that the SPAC transaction was announced, shares of Nauticus Robotics’ stock have fallen in value from approximately $10.00 per share to a current trading price of approximately $2.10 per share, a cumulative decline in value of approximately 80%.

The firm’s investigation seeks to determine whether Nauticus Robotics and/or the company’s representatives violated the securities laws or breached their fiduciary duties to stockholders in connection with the business combination, thereby causing investor losses.

Nauticus Robotics investors who purchased or acquired shares of KITT / CLAQ stock prior to July 27, 2022 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/nauticus-robotics/, for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NASDAQ:KITT

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Select Medical Holdings Shareholder Buyout and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) on behalf of the company’s shareholders to determine whether the recently announced proposed buyout of SEM shareholders is fair and provides investors with sufficient monetary consideration for their shares.Click here for additional information: https://kaskelalaw.com/case/select-medical/On March 2, 2026, Select Medical announced that it had agreed to...

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Global Business Travel Group Inc. Shareholder Buyout and Encourages Investors to Contact the Firm – GBTG

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Global Business Travel Group, Inc. (NYSE: GBTG) (“Amex GBT”) on behalf of the company’s shareholders to determine whether the recently announced buyout of GBTG shareholders is fair and provides investors with sufficient monetary consideration for their shares. Click here for additional information: https://kaskelalaw.com/case/global-business-travel-group/ On May 4, 2026, Amex GBT announced that it had agreed to...

TRADEWEB: Kaskela Law Firm Announces Investigation of Tradeweb Markets Inc. (TW) and Encourages Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Tradeweb Markets Inc. (NASDAQ: TW) (“Tradeweb”) on behalf of the company’s investors. The investigation seeks to determine whether Tradeweb and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Tradeweb shareholders who would like to learn more about the investigation and their legal rights and options are encouraged...
Back to Newsroom